Posted by Michael Wonder on 28 May 2020
Technegas – US FDA new drug application – next milestone in approval process successfully achieved
27 May 2020 - Cyclopharm is pleased to announce that the Company, through its wholly owned subsidiary Cyclomedica Australia, has been granted approval to file status for its New Drug Application for Technegas.
Following this approval Cyclopharm will now proceed to the next stage of the USFDA approval process – review.
